Access and R&D, Nature Medicine, Canada, United States
development
- Soaring drug prices could bar access to future coronavirus treatments (Guardian)
- COVID-19 exposes drug supply gaps as Canada explores local ‘Made in Canada’ solutions (CTV News)
- To deliver a COVID-19 vaccine equitably, we must start planning now (Devex)
- U.S. taxpayer funding contributed to research for a remdesivir patent that will likely remain inaccessible to many people due to the $4,500 price tag by Gilead (STAT)
- Protect against market exclusivity in the fight against COVID-19 (Nature Medicine)
- Compulsory Licensing: A Cure for Distributing the Cure? (CSIS)
- Mobile apps that allow real-time tracking of self-reported symptoms are effective in predicting infections, according to a new study in Nature Medicine
global $bheku_post_types_formatted_taxonomies;
$tax_group = [ 'relation' => 'OR' ];
foreach ( $bheku_post_types_formatted_taxonomies as $tax ) {
if ( $tax == 'topic' || $tax == 'organisation' ) continue;
if ( '' !== bheku_entry_terms(get_the_ID(), $tax, false, 'list') ) {
$tax_group[] = [
'taxonomy' => $tax,
'field' => 'name',
'terms' => explode( ',', bheku_entry_terms(get_the_ID(), $tax, false, 'list') ),
'compare' => 'LIKE',
];
}
}
if ( $tax_group == [ 'relation' => 'OR' ] ) $tax_group = [];
$tax_query = new WP_Tax_Query( $tax_group );
// echo '